Pembrolizumab in relapsed/refractory classical Hodgkin lymphoma: Primary end point analysis of the phase 2 keynote-087 study Meeting Abstract
| Authors: | Moskowitz, C. H.; Zinzani, P. L.; Fanale, M. A.; Armand, P.; Johnson, N. A.; Radford, J. A.; Ribrag, V.; Molin, D.; Vassilakopoulos, T. P.; Tomita, A.; von Tresckow, B.; Shipp, M. A.; Gustafson, E.; Zhang, Y.; Ricart, A. D.; Balakumaran, A.; Chen, R. W. |
| Abstract Title: | Pembrolizumab in relapsed/refractory classical Hodgkin lymphoma: Primary end point analysis of the phase 2 keynote-087 study |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Start Page: | 1107 |
| Language: | English |
| ACCESSION: | WOS:000394446803138 |
| DOI: | 10.1182/blood.V128.22.1107.1107 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 624 -- Source: Wos |
